KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilent Technologies (A) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Agilent Technologies (A) over the last 17 years, with Q4 2025 value amounting to $1.8 billion.

  • Agilent Technologies' Cash & Equivalents rose 3461.25% to $1.8 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $1.8 billion, marking a year-over-year increase of 3461.25%. This contributed to the annual value of $1.8 billion for FY2025, which is 3461.25% up from last year.
  • Latest data reveals that Agilent Technologies reported Cash & Equivalents of $1.8 billion as of Q4 2025, which was up 3461.25% from $1.5 billion recorded in Q3 2025.
  • Agilent Technologies' 5-year Cash & Equivalents high stood at $1.8 billion for Q4 2025, and its period low was $1.1 billion during Q4 2022.
  • For the 5-year period, Agilent Technologies' Cash & Equivalents averaged around $1.4 billion, with its median value being $1.4 billion (2021).
  • Per our database at Business Quant, Agilent Technologies' Cash & Equivalents tumbled by 2904.31% in 2022 and then surged by 5099.72% in 2023.
  • Over the past 5 years, Agilent Technologies' Cash & Equivalents (Quarter) stood at $1.5 billion in 2021, then decreased by 29.04% to $1.1 billion in 2022, then soared by 51.0% to $1.6 billion in 2023, then fell by 16.42% to $1.3 billion in 2024, then soared by 34.61% to $1.8 billion in 2025.
  • Its Cash & Equivalents was $1.8 billion in Q4 2025, compared to $1.5 billion in Q3 2025 and $1.5 billion in Q2 2025.